A general approach to silicatenanoshells: gadolinium silicate and gadolinium silicate:europium nanoshells for dual-modality optical and MR imaging

Literature Information

Publication Date 2009-04-20
DOI 10.1039/B904258J
Impact Factor 6.222
Authors

Chih-Chia Huang, Wileen Huang, Chieh-Ning Feng, Wen-Shuo Kuo, Chen-Sheng Yeh


View Original

Abstract

A general approach involving a solvothermal method was developed to synthesize a series of silicatenanoshells (<100 nm) where both Gd silicate and Gd silicate:Eu nanoshells were further demonstrated to exhibit dual-modality MRI and optical imaging functions.

Related Literature

Design, synthesis, and antiviral activities of myricetin derivatives containing pyridazinone

Li Xing, Youshan An, Yishan Qin, Hui Xin, Tianyu Deng, Kaini Meng, Da Liu, Wei Xue

2023-12-01 Paper

DOI: 10.1039/D3NJ04902G

A specific amino-based fluorescent probe for mercury ion detection in water samples, cells, and zebrafish

Miaohui Yu, Tingting Fu, Wenzhai Li, Yan Zhang, Huayan Wen, Min Zheng, Moran Shi, Caiyun Liu, Meng Jin, Kechun Liu, Baocun Zhu

2023-11-23 Paper

DOI: 10.1039/D3NJ04746F

Bromination of organic spacer impacts on the structural arrangement, phase transitions, and optical and electrical properties of a hybrid halide compound:[(CH3)3N(CH2)3Br]2PdBr4

Mohamed Saadi, Imen Dakhlaoui, Fadhel Hajlaoui, Nidhal Drissi, Mustapha Zighrioui, Fethi Jomni, Nathalie Audebrand, Marie Cordier

2023-11-24 Paper

DOI: 10.1039/D3NJ04819E

Metal–organic gels: recent advances in their classification, characterization, and application in the pharmaceutical field

Wei Cao, Zezhi Lin, Daoyi Zheng, Jianjun Zhang, Weili Heng, Yuanfeng Wei, Yuan Gao, Shuai Qian

2023-10-20 Review Article

DOI: 10.1039/D3TB01612A

Injectable organo-hydrogels influenced by click chemistry as a paramount stratagem in the conveyor belt of pharmaceutical revolution

Misba Majood, Radhika Chaurasia, Rupesh, Akanksha Singh, Tapan Dey, Omnarayan Agrawal, Yogesh Kumar Verma, Monalisa Mukherjee

2023-10-09 Perspective

DOI: 10.1039/D3TB01674A

Contents list

2023-12-06 Front/Back Matter

DOI: 10.1039/D3TB90229C

Injectable spontaneously formed asymmetric adhesive hydrogel with controllable removal for wound healing

Lei Liang, Xi Li, Zhouying Tan, Min Liu, Yuwei Qiu, Qingyu Yu, Chaojie Yu, Mengmeng Yao, Bingyan Guo, Pengcheng Che, Hong Zhang

2023-10-26 Paper

DOI: 10.1039/D3TB02014B

You might also like

Compound Q&A

Is 6-(3-Fluorophenyl)picolinic acid (CAS: 887982-40-3) safe?

6-(3-Fluorophenyl)picolinic acid is generally considered safe for laboratory use...

887982-40-36-(3-Fluorophenyl)pi...
Compound Q&A

What industries use (3R)-3-Pyrrolidinol (CAS: 2799-21-5)?

(3R)-3-Pyrrolidinol is used in the pharmaceutical industry as a precursor for dr...

2799-21-5(3R)-3-Pyrrolidinol
Compound Q&A

What precautions should be taken when handling (4R,5R)-4,5-Diethoxycarbonyl-2,2-dimethyldioxolane (CAS: 59779-75-8)?

When handling (4R,5R)-4,5-Diethoxycarbonyl-2,2-dimethyldioxolane (CAS: 59779-75-...

59779-75-8(4R,5R)-4,5-Diethoxy...
Compound Q&A

How is 1-(6-Chloroimidazo[1,2-b]pyridazin-3-yl)ethanone (CAS: 90734-71-7) typically synthesized?

1-(6-Chloroimidazo[1,2-b]pyridazin-3-yl)ethanone is often synthesized via a mult...

90734-71-71-(6-Chloroimidazo[1...
Compound Q&A

What is the market or research trend for N-Ethyl-3,4-dimethylbenzylamine (CAS: 39180-83-1)?

The market for N-Ethyl-3,4-dimethylbenzylamine (CAS: 39180-83-1) remains steady,...

39180-83-1N-Ethyl-3,4-dimethyl...
Compound Q&A

What is Tert-butyl 3-(pyrrolidin-1-yl)azetidine-1-carboxylate (CAS: 1019008-21-9)?

Tert-butyl 3-(pyrrolidin-1-yl)azetidine-1-carboxylate is a chemical compound wit...

1019008-21-9Tert-butyl 3-(pyrrol...
Compound Q&A

What regulatory guidelines apply to 1-Bromo-3-chloro-2,4-dimethoxybenzene (CAS: 1228956-93-1)?

1-Bromo-3-chloro-2,4-dimethoxybenzene (CAS: 1228956-93-1) falls under the classi...

1228956-93-11-Bromo-3-chloro-2,4...
Compound Q&A

Is 8-Bromo-2-methyl-3,4-dihydroisoquinolin-1(2H)-one (CAS: 1368622-07-4) safe?

The safety of 8-Bromo-2-methyl-3,4-dihydroisoquinolin-1(2H)-one (CAS: 1368622-07...

1368622-07-48-Bromo-2-methyl-3,4...
Compound Q&A

Is Benzyl [(3S)-2,6-dioxo-3-piperidinyl]carbamate (CAS: 22785-43-9) safe?

Benzyl [(3S)-2,6-dioxo-3-piperidinyl]carbamate is generally safe when handled wi...

22785-43-9Benzyl [(3S)-2,6-dio...
Compound Q&A

How should 1-{[4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]sulfonyl}pyrrolidine (CAS: 928657-21-0) be stored?

1-{[4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]sulfonyl}pyrrolidine s...

928657-21-01-{[4-(4,4,5,5-Tetra...

Source Journal

Chemical Communications

Chemical Communications
CiteScore: 8.6
Self-citation Rate: 4.7%
Articles per Year: 2458

ChemComm publishes urgent research which is of outstanding significance and interest to experts in the field, while also appealing to the journal’s broad chemistry readership. Our communication format is ideally suited to short, urgent studies that are of such importance that they require accelerated publication. Our scope covers all topics in chemistry, and research at the interface of chemistry and other disciplines (such as materials science, nanoscience, physics, engineering and biology) where there is a significant novelty in the chemistry aspects. Major topic areas covered include: Analytical Chemistry Catalysis Chemical Biology and medicinal chemistry Computational Chemistry and Machine Learning Energy and sustainable chemistry Environmental Chemistry Green Chemistry Inorganic Chemistry Materials Chemistry Nanoscience Organic Chemistry Physical Chemistry Polymer Chemistry Supramolecular Chemistry

Recommended Compounds

Recommended Suppliers

Disclaimer
This page provides academic journal information for reference and research purposes only. We are not affiliated with any journal publishers and do not handle publication submissions. For publication-related inquiries, please contact the respective journal publishers directly.
If you notice any inaccuracies in the information displayed, please contact us at support@chemtradehub.com. We will promptly review and address your concerns.